why choose us

First received: September 22, 2022

Clinical Trial: Artesunate Suppositories for the Treatment of HIV-negative Patients With Intra-anal HSIL

Study Status: Completed

Recruit Status: RECRUITING

Condition: Anal High Grade Squamous Intraepithelial Lesion

Study Type: INTERVENTIONAL


Official Title: A Phase II Double Blind, Placebo-controlled, Randomized Trial of Artesunate Suppositories for the Treatment of HIV-negative Patients With Anal High-grade Squamous Intraepithelial Lesions (Anal HSIL)

Brief Summary: This is a phase II double blind, placebo-controlled, randomized study of Artesunate suppositories for the treatment of HIV-negative men and women who have anal high grade squamous intraepithelial lesions (anal HSIL)

Read more